The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Neuphoria Therapeutics Inc. quarterly Current Ratio history and change rate from Q1 2025 to Q3 2025.
Neuphoria Therapeutics Inc. Current Ratio for the quarter ending 30 Sep 2025 was 387%.
Current Ratio, Quarterly (%)
Neuphoria Therapeutics Inc. Quarterly Current Ratio (%)
Period
Value
YoY Chg
Change %
Date
Q3 2025
387%
30 Sep 2025
Q2 2025
430%
30 Jun 2025
Q1 2025
428%
31 Mar 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.